Trial Profile
Comparison of the Efficacy and Safety of Cilnidipine 10mg/Valsartan 160mg Combination Therapy, Cilnidipine 5mg/Valsartan 160mg Combination Therapy and Valsartan 160mg Monotherapy in Hypertensive Patients Inadequately Controlled With Valsartan 160mg Monotherapy: a Multicenter, Randomized, Double Blind Phase III Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cilnidipine/valsartan (Primary)
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Ildong Pharmaceutical
- 11 Jun 2018 Status changed from recruiting to completed.
- 18 May 2015 New trial record